Alaunos Therapeutics reported $1.29M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 1.29M 865K Mar/2026
Amgen USD 9.19B 532M Mar/2026
AstraZeneca USD 47.33B 1.33B Mar/2026
Baxter International USD 6.04B 86M Mar/2026
Biogen USD 18.65B 394.9M Mar/2026
Bioline Rx USD 19.53M 537K Sep/2025
Bristol-Myers Squibb USD 20.07B 1.6B Mar/2026
Celltrion KRW 435.96B 16.26T Dec/2025
Corcept Therapeutics USD 637.99M 9.82M Mar/2026
Cspc Pharmaceutical CNY 33.18B 71.46M Dec/2025
Curis USD 5.46M 19.45M Dec/2025
Deva Holding AS TRY 5.79B 604.07M Sep/2023
Dianthus Therapeutics USD 1.2B 707.91M Mar/2026
Divis Laboratories Ltd INR 154.13B 4.44B Sep/2025
Gilead Sciences USD 23.52B 897M Mar/2026
GlaxoSmithKline GBP 17.42B 1.05B Mar/2026
Incyte USD 5.62B 455.37M Mar/2026
Intrexon USD 43.17M 75.33M Jun/2024
Ionis Pharmaceuticals USD 491.41M 2.32M Mar/2026
J&J USD 81.19B 358M Mar/2026
Kangmei Pharma CNY 7.22B 504.3M Sep/2025
Karyopharm Therapeutics USD -292.93M 23.67M Dec/2025
Knight Therapeutics CAD 767.27M 480K Dec/2025
Laboratorios Farma EUR 539.39M 22.74M Dec/2023
Malin Corporation EUR 193.2M 75M Dec/2024
Medical Developments International AUD 54.77M 335K Dec/2025
Merck USD 45.88B 6.73B Mar/2026
Neuren Pharmaceuticals AUD 338.45M 15.18M Dec/2025
Novartis USD 38.93B 7.2B Mar/2026
Organigram Holdings CAD 369.46M 20.33M Dec/2025
Ovoca Bio EUR 1.26M 7.41M Jun/2025
Pfizer USD 90.1B 3.63B Mar/2026
Pharma Mar EUR 249.67M 2.16M Mar/2026
PTC Therapeutics USD -180.46M 24.85M Mar/2026
Qiagen NV USD 3.78B 128.73M Dec/2025
Regeneron Pharmaceuticals USD 31.42B 166.7M Mar/2026
Roche Holding CHF 33.8B 758M Dec/2025
Sangamo BioSciences USD 19.6M 14.7M Jun/2025
Sartorius EUR 2.73B 1.14B Mar/2026
Sino Biopharmaceutical CNY 34B 1.48B Jun/2025
TG Therapeutics USD 583.13M 64.89M Mar/2026
Tilray USD 1.58B 39.08M Sep/2025
Verastem USD 57.2M 72.72M Dec/2025
Zealand Pharma A/S 14.83B 331.99M Dec/2025
Zz Pientze Pharmaceu CNY 15.21B 740.32M Mar/2026